Canonical: https://ownershiptrace.com/13f/companies/1030

# Who owns EXELIXIS, INC. (EXEL)? Elite investor 13F holders

7 tracked elite investors reported holding EXELIXIS, INC as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Caligan Partners, Gotham Asset Management, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | EXELIXIS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 730617099.00 USD | 13427993.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | EXELIXIS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 302070554.00 USD | 5551747.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Caligan Partners](https://ownershiptrace.com/13f/investors/125) | EXELIXIS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 84512985.00 USD | 1553262.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1727492/0001420506-26-001809-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | EXELIXIS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 48569794.00 USD | 892663.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | EXELIXIS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 21810738.00 USD | 400859.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |
| [GMO](https://ownershiptrace.com/13f/investors/94674) | EXELIXIS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1352662/0001072613-26-000636-index.html) |
| [First Eagle Investment Management](https://ownershiptrace.com/13f/investors/32) | EXELIXIS INC | SHARE | 2026-06-30 | 2026-08-05 00:00:00 | 544100.00 USD | 10000.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1325447/0001325447-26-000020-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | EXELIXIS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 252027.00 USD | 4632.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)